Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

ALIVUS LIFE SCIENCES LTD.

NSE : ALIVUSBSE : 543322ISIN CODE : INE03Q201024Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE889.957.85 (+0.89 %)
PREV CLOSE () 882.10
OPEN PRICE () 881.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3025
TODAY'S LOW / HIGH ()881.65 898.00
52 WK LOW / HIGH ()827.1 1259.75
NSE888.657.25 (+0.82 %)
PREV CLOSE() 881.40
OPEN PRICE () 888.45
BID PRICE (QTY) 888.65 (98)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 55174
TODAY'S LOW / HIGH() 879.50 899.75
52 WK LOW / HIGH ()847.2 1251
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2011

Management Info :

Hiren K Patel - Chairman Yasir Rawjee - Managing Director

Registered Office :

Address : Plot No. 170-172,Chandramouli Industrial Estate,Mohol Bazarpeth,
Solapur,
Maharashtra-413213

Phone : 02189 234456/234246

Website : www.alivus.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
13Nov Alivus Life Sciences informs about ear
Alivus Life Sciences has informed that the transcript of Earnings Call h..
20Oct Alivus Life Sciences informs about di
Pursuant to regulation 30(2) of the Securities and Exchange Board of Ind..
12Aug Alivus Life Sciences informs about new
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosur..
11Aug Alivus Life Sciences submits intimatio
Alivus Life Sciences has informed that the Fourteenth (14th) Annual Gene..
28Jul USFDA issues EIR with NAI classificati
The United States Food and Drug Administration (USFDA) has issued an Est..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit1300.264856.27
Gross Profit 1741.37 6541.31
Operating Profit 1938.97171.54
Net Sales 5879.823868.84
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1128.80 (6.39%)
M.Cap ( in Cr)
777.96
Amrutanjan Healthcar (BSE)
 689.65 (6.38%)
M.Cap ( in Cr)
1993.82
Lupin (BSE)
 2114.10 (1.62%)
M.Cap ( in Cr)
96571.84
Panacea Biotec (BSE)
 362.70 (9.53%)
M.Cap ( in Cr)
2221.56
Emcure Pharma (BSE)
 1439.60 (2.18%)
M.Cap ( in Cr)
27289.76
Shareholding Pattern
PROMOTERS 74.91%
NON-INSTITUTION 12.78%
MUTUAL FUNDS/UTI 3.87%
FI/BANKS/INSURANCE 0.24%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX85267.66449.53 (0.53%)
NIFTY26046.95148.40 (0.57%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI